Log in or Sign up
to access My Account functionalities
Tranexamic acid intravenous formulations – Serious including fatal adverse reactions due to inadvertent intrathecal administration
Joint DHPC 30th April 2026 - Tranexamic acid intravenous formulations – Serious including fatal adverse reactions due to inadvertent intrathecal administration